INTRODUCTION
The growth hormone (GH)/insulin-like growth factor (IGF1) axis is responsible for somatic development, while pituitary GH synthesis and secretion represent the integrated processes, controlled by hypothalamic, intrapituitary and peripheral signals, *Corresponding author: e-mail: dimi@ibiss.bg.ac.rs
Research article
Somatopause, the complex aspect of andropause, is recognizable by reduced growth hormone -GH/insulin-like growth factor 1 axis function in the ageing male. Soy isofl avones (usually genistein and daidzein), which are known for their benefi cial effects in the treatment of ageing symptoms, are active in the pituitary, as well. The immunohistomorphometric and -fl uorescent characteristics of pituitary growth hormone secreting cells, in an animal model of andropause, were examined after a treatment with genistein or daidzein. Andropausal Wistar rats were divided into sham operated, orchidectomized and genistein or daidzein treated orchidectomized groups. Genistein or daidzein (30 mg/kg/day) were administered subcutaneously for three weeks, while sham operated and orchidectomized groups received the vehicle alone. Growth hormone secreting cells were identifi ed by the peroxidase-antiperoxidase immuno-histochemical, and immuno-fl uorescent procedure. The main characteristic of growth hormone secreting cells in soy isofl avones treated groups is a weaker immuno-histochemical staining and immuno-fl uorescent signal compared to sham operated and orchidectomized groups. The growth hormone secreting cell volume in orchidectomized +genistein or +daidzein groups is by 13.8% and 11.9% (p<0.05) smaller respectively, in comparison with the orchidectomized group. In orchidectomized +genistein or +daidzein groups, the growth hormone secreting cells relative volume density is by 62.5% and 61.0% lower (p<0.05) respectively than for the sham operated group, and decreased by 65.4% and 64.0% (p<0.05) respectively, compared to the orchidectomized group. It can be concluded that chronic genistein or daidzein treatment, in an animal model of andropause, attenuates immunohistomorphometric and -fl uorescent characteristics of growth hormone secreting cells.
all of which converge on the GH cells [1] as the specifi c GH/IGF1 axis operative component. Andropause represents the culminating phase of ageing in males [2] , i.e. the specifi c multi-symptomatic syndrome that is inter alia characterized by reduced GH/IGF1 axis function [3] , which opens a specifi c thematic subfi eld -somatopause within the andropause. An age-related imbalance between the hypothalamic release of somatostatin and the growth hormone releasing-hormone (GHRH) causes a morphofunctional weakening of GH cells [4, 5] with a signifi cant decrease in GH cells size and GH content per cell, as well as the GH pulse amplitude decline [6] [7] [8] . These changes appear to be followed by some adverse somatic consequences [9] . During the past several decades, soy isofl avones (usually genistein and daidzein), the compounds structurally and functionally similar to 17β-estradiol, have gained signifi cant attention from the scientifi c community, primarily owing to their benefi cial effects in the treatment of various ageing symptoms. On the other hand, data illustrating the effects of genistein or daidzein on the GH/IGF1 axis at different ages, and especially their effect on the pituitary GH cells histological characteristics, are limited. It was observed that genistein effi ciently stimulates GH secretion in adult ewes, which is refl ected in reduced GH deposition in the GH cells and elevated plasma GH levels [10] . Considering the negligible amount of estrogen receptors (ER) in GH cells [11] , the authors proposed an indirect mechanism of genistein activity, via growth hormonereleasing hormone (GHRH) [10] . The elaborated GH secretion promoting effect of genistein may encourage its potential therapeutic use in somatopause, while daidzein, inactive in the GHRH potentiation [12] , still has a debatable potential role in this complex age-related condition. Keeping in mind the silencing of the GH/IGF1 axis with ageing, the following negative morphofunctional transformation of GH cells (as the specifi c axis operative component), as well as a promising role of soy isofl avones in GH cells stimulation, the aim of this study was to investigate the effects of chronic subcutaneous treatment with genistein or daidzein on immuno-histomorphometric and fl uorescent characteristics of GH cells in an animal model of andropause. Our ambition was to supplement the data 'pool' in the neglected aspect of GH cells histological characteristics, after the soy isofl avones application in advanced age. Orchidectomy was performed to eliminate testicular sex steroids from the hormonal millieu and their potential effects on the GH cells.
MATERIALS AND METHODS

Animals and diets
The experiments involved 16-month-old (andropausal) male Wistar rats. They were bred at the Institute for Biological Research "Siniša Stanković", Belgrade, Serbia, housed one per cage, exposed to a 12-12 h light-dark cycle and kept at 22±2ºC. Two weeks before the experiment, the rats were given a soy-free diet, prepared in cooperation with the Department of Animal Nutrition and Botany, Faculty of Veterinary Medicine, Belgrade, Serbia, and INSHRA PKB, Belgrade, Serbia, according to Picherit et al., (2000) [13] and our previous studies [14] [15] [16] , with corn oil as the fat source. 
Animal treatments
At the age of 15 months experimental animals were bilaterally orchidectomized (Orx; n=24 animals) or sham-operated (SO; n=8 animals) under Ketamine anesthesia (15mg/ kg b.w.; Richter Pharma, Wels, Austria). The recovery period lasted two weeks. The orchidectomized rats were then divided into three groups of eight animals (n=8) each. The fi rst group was subcutaneously treated with genistein (Nutraceutica, Monterenzio, Bologna, Italy; Orx+G), in a dose of 30 mg/kg b.w., every day except on Sundays, for 3 weeks. The second orchidectomized group received daidzein (Nutraceutica, Monterenzio, Bologna, Italy; Orx+D) at 30 mg/kg b.w., following the same regime. Genistein and daidzein were predissolved in a minimal volume of absolute ethanol (0.17 ml) and mixed with sterile olive oil (0.33 ml). The fi nal volume injected was 0.5 ml per animal. The third orchidectomized group (Orx) and the SO group were given the same volume (0.5 ml) of vehicle alone. Body mass in all groups was weighted before the surgery, before the treatment and after the treatment. All the animals (n=32) were sacrifi ced by decapitation under ether anesthesia (ether ad narcosis Ph. Iug. III., Lek, Ljubljana, Slovenia) 24 h after the last injection. All experimental procedures were in compliance with the EEC Directive (86/609/EEC) on the protection of animals used for experimental and other scientifi c purposes, and were approved by the Ethical Committee for the Use of Laboratory Animals of the Institute for Biological Research "Siniša Stanković", University of Belgrade.
Light microscopy and immuno-histochemistry
The pituitary glands were excised, fi xed in Bouins' solution for 48 h and embedded in paraplast. Serial 5 m thick tissue sections were deparafi nised in xylol and rehydrated in a series of decreasing concentrations of ethanol. For light microscopy analysis, GH cells were immunolabelled using the peroxidase-antiperoxidase complex (PAP) method of Sternberger et al. (1970) [17] . The endogenous peroxidase activity was blocked by incubation in 9 mmol (0.3%) hydrogen peroxide solution in methanol, for 15 min at 24°C. Before the application of the specifi c primary antisera, nonspecifi c background staining was prevented by incubation of the sections with nonimmune, i.e. normal porcine serum, diluted (1:10) with phosphate buffered saline (PBS) pH 7.4, for 60 min at 24°C. Sections were then overlaid with the appropriate dilutions of the specifi c primary antibodies (hGHantisera, Dako A/S, Glostrup, Denmark; diluted 1:200 in PBS) for 24 h at 24°C. This antibody strongly cross-reacts with rat GH [18] . After washing in PBS for 5 min, sections were incubated for 60 min at 24°C with a secondary antibody, swine antirabbit IgG (DAKO, Glostrup, Denmark; diluted 1:100 in PBS), rinsed again in PBS for 5 min and then incubated with rabbit PAP complex (DAKO A/S, Glostrup, Denmark; diluted 1:100 in PBS), for 45 min at 24°C. Binding sites were visualized using 0.05% diaminobenzidine (DAB, Serva, Heidelberg, Germany) and 0.03% hydrogen peroxide in 0.2 M TRIS-HCl buffer, pH 7.4. The sections were counterstained with hematoxylin and mounted in Canada balsam (Molar Chemicals KFT, Budapest, Hungary). For the negative control sections, the primary antibody was omitted and replaced by PBS.
Immuno-fl uorescent studies
GH cells were also localized immuno-fl uorescently. In brief, the pituitary sections were deparafi nised, rehydrated, washed in PBS and pretreated with blocking normal donkey serum (Dako, Glostrup, Denmark), diluted in PBS (1:10). After blocking, sections were incubated overnight at 24°C with the specifi c primary antibodies (hGHantisera, Dako A/S, Glostrup, Denmark; diluted 1:200 in PBS). After rinsing in PBS, the sections were covered, for 2 h at 24°C, with secondary antibody Alexa Fluor 488 donkey anti-rabbit IgG (Molecular Probes, Inc., USA; 1:200). Finally, sections were rinsed fi ve times in PBS and mounted using Mowiol 4-88 (Sigma-Aldrich, Co., USA). Carl Zeiss AxioVision microscope (Zeiss, Germany) was used for the section analysis. The negative controls were obtained by replacement of the primary antibody with a PBS. Analysis of fl uorescent images was performed using the Image J 1.47 (public domain Java image processing program by National Institutes of Health (NIH)). The relative intensity of fl uorescence (RIF, %) was measured on 100-150 cells per animal in which the nucleus was apparent.
Morphometry
Morphometrical measurements were performed as described previously [14, 15] . Namely, two pituitary sections (5 μm thick) from the superior, three from the middle and two from the inferior part (seven horizontal sections, 20 μm apart in total) of the rat pituitary glands were analysed. The point counting method was used at an overall magnifi cation of x1000 [19] . The M 42 multipurpose test grid, inserted into the ocular of a Zeiss light microscope (Jena, Germany), was randomly positioned on the pituitary section at the beginning of counting. Counting was carried out on the following 50 test fi elds per section. Average values were calculated per pituitary i.e. per animal (7 sections, 350 test fi elds) and fi ve pituitaries were analyzed per group. Cell volume (Vc, μm [20] , the shape coeffi cient β for pituitary cells was estimated to be 1.32, where k is a factor related to cell distribution according to their size (in the case of GH cells its value is 1) and N A is the number of cells in the plane of the pituitary tissue section. N A is calculated as follows: N A = ΣNn/ΣPtc · a , where a represents the rhombic area belonging to every point of the test system and is calculated using the formula: a = d 2 3
1/2 /2 , where d is the test line length in the test system employed. Volume density (V VC ) is calculated as the ratio of the sum of Pn and Ptc (Pn+Ptc) and the total number of points in the test system. Since the test system with 42 points was used and parameters were calculated using 50 test fi elds, the defi nite formula was: V VC = (Pn+Ptc)/ 50 · 42
Statistical analysis
STATISTICA ® version 7.0 (StatSoft, Inc.) was used for the statistical analysis. Morphometric and RIF data obtained for the experimental groups were subjected to one-way analyses of variance (ANOVA). Duncan's multiple range tests were used for post hoc comparisons between groups. A confi dence level of p<0.05 was considered statistically signifi cant. The data are presented as means±SD.
RESULTS
Body mass and pituitary weights
Data for body mass, absolute and relative pituitary weights are summarized in Table  1 . Only in the Orx group the body mass after treatment was signifi cantly (p<0.05) decreased (by 9.8%), in comparison with the SO group. Genistein or daidzein treatment, after orchidectomy, returned the body mass to the values similar to that of SO rats. Absolute pituitary weight was signifi cantly (p<0.05) increased in Orx+D group by 8.4%, compared to the Orx group. The relative pituitary weights were signifi cantly (p<0.05) increased in Orx, Orx+G and Orx+D groups by 13.6%, 40.9% and 31.8% respectively, in comparison with the SO group. The relative pituitary weight increased by 24.0% (p<0.05) for the Orx+G and by 15.0% for the Orx+D, compared to the Orx group.
Immuno-histochemical fi ndings
Immunopositive GH cells in SO and Orx rat pituitaries are mainly uniformly distributed, bilaterally and rostrocaudally, in the pars distalis, while being completely absent in the pituitary pars intermedia. They can be observed as an individual or as a group, especially along the sinusoidal capillaries (Fig. 1A, B) . SO and Orx rat pituitary GH cells appear to be massive, ovoid to pyramidal in shape, with a spherical, centrally located nucleus. The immunospecifi c signal, refl ecting the cells' GH content, is rather dark and widely distributed throughout the cytoplasm (Fig. 1A, B) . In Orx+G and Orx+D rat pituitaries, a small number of immunopositive GH cells can be observed; they appear as an individual or in the form of small groups, along the sinusoidal capillaries (Fig. 1C, D) . The main characteristic of GH cells in soy isofl avones treated groups of rats is enlightened cytoplasm (a weaker intensity of immunospecifi c staining compared to the control groups), while the pituitary capillaries, towards which GH cells gravitate, are dilated (Fig. 1C, D) .
Immuno-fl uorescent fi ndings
Complementary insight into the immuno-fl uorescent appearance of GH cells confi rmed a weaker signal after the soy isofl avone treatments, compared to the control groups ( Fig.  2A-D) . Quantifi cation of the signal revealed that in Orx+G rats RIF is decreased by 41.8% and 44.8% (p<0.05) in comparison with the SO and Orx group, respectively (Fig. 2E) . Daidzein treatment of orchidectomized andropausal rats (Orx+D) also causes the decrease of RIF for 47.3% and 50.0% (p<0.05) compared to the SO and Orx group, respectively.
Morphometric results
Morphometric analyses showed that GH cells in SO, Orx, Orx+G and Orx+D groups of rats have a mean cell volume (Vc) of 591 μm (Fig. 3A) . In comparison with SO and Orx groups, the GH cell volume in Orx+G group is 18.4% and 13.8% (p<0.05) smaller, respectively (Fig. 3A) . The mentioned parameter in Orx+D group of rats is also signifi cantly (p<0.05) decreased compared to SO and Orx groups, by 16.8% and 11.9% respectively (Fig. 3A) . After orchidectomy and orchidectomy followed by soy isofl avones treatment there are no signifi cant (p>0.05) changes in the nuclear volumes of GH cells, in comparison with the SO group (Fig. 3B) . The GH cells relative volume density data (Vvc; %) in SO, Orx, Orx+G and Orx+D groups are shown in Fig. 3C (36.0%, 39.0%, 13.5% and 14.2% respectively). Namely, in Orx+G and Orx+D, the relative volume densities are by 62.5% and 61.0% lower (p<0.05) respectively, than for the SO controls (Fig. 3C) . The same parameter in Orx+G and Orx+D is signifi cantly (p<0.05) decreased by 65.4% and 64.0% respectively, compared to Orx group (Fig. 3C) .
DISCUSSION
Considering the promising data regarding the soy isofl avone effects in ageing, somewhat of their GH/IGF1 axis stimulation, as well as the limited information about the GH cells appearance in this context, our intention was to determine the immunohistomorphometric and -fl uorescent characteristics of GH cells in andropausal rats, after chronic genistein or daidzein treatment. In line with our previous fi ndings [14, 15] , genistein or daidzein application to orchidectomized andropausal rats has some recovering body mass effect, i.e. it brings body mass values close to that of SO rats. We have already demonstrated the pronounced daidzein effects on the prevention of bone loss and calcium excretion in the same animal model [21] , while Penza et al. [22] observed that nutritional doses of genistein are adipogenic in male mice, all of which can cause the positive body weight outcome in our experiment. It should be mentioned that some studies suggest the absence of soy isofl avones effect on body mass [23] , so the cautiousness in concluding is desirable. On the other hand, given the age of animals in our study and their long-ended growth, it is quite reasonable to minimize the importance of some potentional genistein or daidzein A weaker intensity of immuno-histochemical staining and immuno-fl uorescent signal of GH cells, followed by their decreased volume and volume density, compared to both SO and Orx groups, is observed after genistein or daidzein application in our experiment. Genistein, operating as a tyrosine-kinase inhibitor, promotes GHRHstimulated cAMP accumulation in GH cells, which potentiates their hormonal content secretion [12] . This mechanism may satisfactorily clarify the observed appearance of the cytoplasm of GH cells after genistein treatment in our study. Furthermore, genistein treatment lowered the density of the immunoreactive material in GH cells of ewes, which indicates decreased hormone storage [10] . Daidzein, although a weak tyrosinekinase inhibitor [24] , fashions in a similar manner as genistein in orchidectomized andropausal rats, which opens the space for some other possible mechanisms of soy isofl avone actions pertinent to GH cells. Literature data indicate the possible alterations in somatostatin receptors (SSTRs) expression after genistein application in vitro, as a matter of fact the SSTR1 downregulation, as well as the SSTR2 and SSTR5 upregulation [25] . Considering that an alternative SSTR expression in pituitary GH secreting tumors causes the insensitivity to somatostatin [26] , it seems logical that some soy isofl avone modifi ed SSTR expression in GH cells may have a related outcome responsible for Somatopauza, kao kompleksan aspekt andropauze, je prepoznatljiva po sniženom nivou funkcije somatotropne -GH ose kod starih mužjaka. Izofl avoni soje (najčešće genistein i daidzein), imaju blagotvorne efekte pri tretmanu simptoma starenja, a ispoljavaju svoje dejstvo i na nivou hipofi ze. Imuno-histomorfometrijske i -fl uorescentne karakteristike hipofi znih somatotropnih ćelija su ispitivane nakon tretmana genisteinom ili daidzeinom, u animalnom modelu andropauze. Pacovi Wistar soja u andropauzi su podeljeni u nekoliko grupa: prividno operisanu, orhidektomisanu i genisteinom odnosno daidzeinom tretiranu orhidektomisanu grupu. Rastvoreni genistein, odnosno daidzein (30 mg/kg/dan) su potkožno davani tokom tri nedelje, dok su prividno operisana i orhidektomisana grupa dobijale samo rastvarač tokom istog perioda. Somatotropne ćelije su identifi kovane peroksidaza-antiperoksidaza imuno-histohemijskom, i imunofl uorescentnom metodom. Osnovna karakteristika somatotropnih ćelija u grupama tretiranim izofl avonima soje je slabije imuno-histohemijsko bojenje i slabiji imunofl uorescentni signal u poređenju sa prividno operisanom i orhidektomisanom grupom. Volumen somatotropnih ćelija u orhidektomisanoj i genisteinom, odnosno daidzeinom tretiranoj grupi je za 13,8%, odnosno 11,9% (p<0,05) smanjen u poređenju sa orhidektomisanom grupom. U orhidektomisanoj i genisteinom, odnosno daidzeinom tretiranoj grupi volumenska gustina somatotropnih ćelija je za 62,5%, odnosno 61,0% niža (p<0,05) nego kod prividno operisane grupe, te za 65,4%, odnosno 64,0% (p<0,05) niža u poređenju sa orhidektomisanom grupom. Može se zaključiti da hronični tretman genisteinom ili daidzeinom, u animalnom modelu andropauze, ima negativan efekat na imuno-histomorfometrijske i -fl uorescentne karakteristike somatotropnih ćelija.
